CLINICAL EVIDENCE

The Science Behind CareCentra

Real-world clinical evidence from 1,200 patients at Intermountain Health validates what we set out to prove: continuous, connected care prevents hospitalizations and improves lives.

Published Study Coming SoonRequest a Conversation

THE iCARE STUDY

Validating a New Model of Respiratory Care

The iCARE study (Intermountain COPD and Adult Asthma Remote Evaluation) is a 24-month clinical program running from March 2024 through March 2026 at Intermountain Health — one of the largest integrated health systems in the US.

The study tests whether AI-powered continuous monitoring, combined with human care teams, can shift respiratory care from reactive to predictive — catching exacerbations before they happen.

1k

patients reported surveys analyzed

5

regional hospitals across IMH

124k

FEV1 + PEF signals processed

740k

nudges delivered

29k

H/M alerts acted upon

7

PDNs cared for 1200 patients

KEY OUTCOMES

What the Data Shows

Interim results across 1,200 high-severity COPD and asthma patients.

Hospitalizations

67%

reduction in inpatient encounters

3.27 → 0.93 per patient-year (p=0.0001)

Readmissions

33%

reduction in 30-day readmissions

35% for COPD, 37% for asthma

Length of Stay

57%

reduction in total inpatient hours

53% for COPD, 67% for asthma

Emergency Visits

19%

reduction in ED encounters

Total Cost of Care

46%

reduction in per-patient costs

$28,235 → $13,000 per patient-year (p=0.018)

Medication Adherence

67%

daily controller adherence (COPD)

64% for asthma vs. 15-30% typical

SEVEN OBJECTIVES VALIDATED

What We Set Out to Prove

The iCARE study was designed to validate seven core hypotheses about continuous, connected respiratory care.

1

Predictive Intervention Works

Self-learning algorithms detect rising risk and trigger intervention before exacerbations escalate.

67% fewer hospitalizations

2

Multimodal Signals Outperform Single-Domain Monitoring

Integrating adherence, physiology, environment, and emotional health provides superior predictive capability.

3

Digital Health Twins Work at Scale

Real-time computational profiles can be deployed in routine clinical practice.

696 patients. Multiple sites.

4

Comprehensive Adherence Monitoring Is Possible

The platform captures technique quality, inspiratory flow, timing, and environmental context.

679 inadequate-flow alerts addressed

5

AI Augments Human Care

Pulmonary Disease Navigators use AI-generated risk signals to prioritise outreach.

6

Patients Engage — Even Older Adults

Engagement increases with age — older patients use the app more, not less.

Engagement increases by 0.40% for every additional year of age (p < 0.001).

7

Precision Nudging Shapes Behaviour

Personalised micro-interventions drive sustained behaviour change.

HOW THE PLATFORM COLLECTS DATA

Multimodal Risk Signals

CareCentra integrates data from multiple sources to build a complete picture of each patient's risk trajectory.

Connected Devices

Smart inhaler jackets track medication use, technique, and timing. Pulse oximeters capture oxygen saturation.

Environmental Data

Real-time air quality (PM2.5, ozone) integrated by ZIP code with patient alerts.

Patient-Reported Outcomes

CAT, ACT, PHQ-9, STOP-BANG captured via the app and incorporated into the digital twin.

Optional Wearables

Smartwatches, pedometers, and BP cuffs can feed additional data with consent.

PRECISION NUDGES IN ACTION

Examples of Adaptive Intervention

The platform delivers personalised nudges based on real-time signals — not generic reminders.

Inhaler technique correction

Your inhaler technique looks a bit off today — want a 20-second refresher?

Triggered by: Smart inhaler flow pattern anomalies

Environmental alert

Air quality is dropping outside. Close windows and keep your rescue inhaler nearby.

Triggered by: AQI data + geolocation

Early symptom detection

Your breathing pattern looks tighter. Try a 2-minute paced breathing reset.

Triggered by: Drop in HRV + increased respiratory rate

Adherence reminder

Time for your controller inhaler — taking it now keeps symptoms from creeping up.

Triggered by: Missed scheduled dose

See the Evidence for Yourself

Download the full iCARE study results or schedule a conversation with our clinical team.

Published Study Coming SoonStart a Conversation